Shares of Phibro Animal Health Corporation (PAHC) surged over 5% in extended trading on Wednesday, following the company's impressive fiscal second-quarter results and an upbeat full-year revenue forecast.

For the quarter ended December 31, 2024, Phibro reported adjusted earnings per share of $0.54, comfortably beating analysts' expectations of $0.42. The animal health and mineral nutrition company's revenue grew nearly 24% year-over-year to $309.3 million, also exceeding consensus estimates of $303.84 million.

Notably, Phibro raised its fiscal 2025 revenue guidance to a range of $1.25 billion to $1.30 billion, compared to analysts' average projection of $1.32 billion. The company cited strong demand across its animal health and nutrition businesses for the upbeat outlook.